Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 2.90 is 48% below its 5-year average of 5.58, near the low end of its 5-year range (2.90–14.28).
As of the fiscal period ended Tuesday, June 30, 2026. 17.95% below its 12-month average of 3.54.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.90.
CURRENT RATIO
2.90
CURRENT RATIO AVG TTM
3.54
CURRENT RATIO AVG 3Y
4.07
CURRENT RATIO AVG 5Y
5.58
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-17.95%
CURRENT VS 3Y AVG
-28.66%
CURRENT VS 5Y AVG
-48.02%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
-22.59%
vs the sector median at left
Treace Medical Concepts, Inc.
Market Cap
$259.49M
Current Ratio
2.90
TTM Avg
3.54
3Y Avg
4.07
5Y Avg
5.58
Market Cap
$259.56M
Current Ratio
8.88
TTM Avg
8.27
3Y Avg
7.75
5Y Avg
6.94
Market Cap
$259.14M
Current Ratio
16.00
TTM Avg
13.11
3Y Avg
8.33
5Y Avg
7.81
Market Cap
$259.12M
Current Ratio
13.89
TTM Avg
8.37
3Y Avg
7.38
5Y Avg
15.00
Market Cap
$261.27M
Current Ratio
11.30
TTM Avg
6.79
3Y Avg
6.17
5Y Avg
6.32
Market Cap
$261.43M
Current Ratio
15.82
TTM Avg
24.04
3Y Avg
14.70
5Y Avg
12.06
Market Cap
$262.92M
Current Ratio
5.35
TTM Avg
2.41
3Y Avg
1.69
5Y Avg
2.06
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Treace Medical Concepts, Inc. (TMCI) | $259.49M | 2.90 | 3.54 | 4.07 | 5.58 |
| OraSure Technologies, Inc. (OSUR)vs › | $259.56M | 8.88 | 8.27 | 7.75 | 6.94 |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $259.14M | 16.00 | 13.11 | 8.33 | 7.81 |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $259.12M | 13.89 | 8.37 | 7.38 | 15.00 |
| Palisade Bio, Inc. (PALI)vs › | $258.63M | 24.26 | 16.09 | 10.56 | 7.83 |
| X4 Pharmaceuticals, Inc. (XFOR)vs › | $261.27M | 11.30 | 6.79 | 6.17 | 6.32 |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $261.43M | 15.82 | 24.04 | 14.70 | 12.06 |
| AC Immune S.A. (ACIU)vs › | $256.47M | 0.93 | 1.36 | 5.78 | 8.29 |
| TriSalus Life Sciences, Inc. (TLSI)vs › | $262.92M | 5.35 | 2.41 | 1.69 | 2.06 |
| Anika Therapeutics, Inc. (ANIK)vs › | $255.88M | 4.48 | 4.80 | 5.23 | 5.23 |
Current Ratio
2.90
Quick Ratio
1.95
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 2.90 |
| 2026-03-31 | 3.58 |
| 2025-12-31 | 4.31 |
| 2025-09-30 | 3.37 |
| 2025-06-30 | 3.52 |
| 2025-03-31 | 4.50 |
| 2024-12-31 | 4.62 |
| 2024-09-30 | 4.12 |
| 2024-06-30 | 3.86 |
| 2024-03-31 | 3.98 |
| 2023-12-31 | 4.40 |
| 2023-09-30 | 5.64 |
| 2023-06-30 | 6.60 |
| 2023-03-31 | 9.58 |
| 2022-12-31 | 4.41 |
| 2022-09-30 | 5.66 |
| 2022-06-30 | 8.13 |
| 2022-03-31 | 8.28 |
| 2021-12-31 | 7.58 |
| 2021-09-30 | 12.62 |
| 2021-06-30 | 14.28 |
| 2021-03-31 | 4.24 |
| 2020-12-31 | 3.53 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
